Frazier Life Sciences Management
Finance · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1001 Page Mill Rd Ste 200 Bldg 4, Palo A...Phone Number
(650) 325-5156Website
www.frazierls.comRevenue
$24.5 MillionIndustry
About Frazier Life Sciences Management
Frazier Life Sciences is a longstanding biotech investment firm that employs both venture and public strategies to partner with and build companies focused on developing novel therapeutics. The firm has managed over $5.3 billion in capital since 2015, supporting innovation at every stage and creating more than 25 companies. With a strong emphasis on collaboration, Frazier's team is known for their high intellect and integrity, providing resources and guidance to their portfolio companies. They have achieved significant milestones, including over 75 FDA approved drugs and numerous IPOs and M&As, representing a cumulative transaction value of $75 billion.Explore more
SIC Code 61,615NAICS Code 52,523Show more
Frazier Life Sciences Management Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Frazier Life Sciences Management
Compare insights from companies similar to Frazier Life Sciences Management, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Frazier Life Sciences Management Tech Stack
A closer look at the technologies used by Frazier Life Sciences Management
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Frazier Life Sciences Management
Sign Up For FreeTo access detailed company insights
Frazier Life Sciences is a longstanding biotech investment firm that employs both venture and public strategies to partner with and build companies focused on developing novel therapeutics. The firm has managed over $5.3 billion in capital since 2015, supporting innovation at every stage and creating more than 25 companies. With a strong emphasis o... Read More
